Medical/Pharmaceuticals

tHIS ASEAN 2025 to Debut in Kuala Lumpur, Uniting Southeast Asia's Healthcare Powerhouses

KUALA LUMPUR, Malaysia, May 29, 2025 /PRNewswire/ -- The Health Industry Series - ASEAN (tHIS ASEAN 2025), a groundbreaking event aimed at integrating healthcare resources across Southeast Asia, is set to take place in Kuala Lumpur during June 9-11. Co-located with the APHM International Healthca...

2025-05-29 19:22 2771

Acclaro Medical Raises $23 Million in Series B Funding Led by Accelmed Partners to Advance Groundbreaking 2910 nm Fiber Laser Technology

* Accelmed $20 Million Investment with 3E Bioventures Capital Funding of $3 Million to Drive Innovation, Clinical Expansion, and Global Market Growth SMITHFIELD, R.I., May 29, 2025 /PRNewswire/ -- Acclaro Medical, a pioneering medical technology company focused on developing cutting-edge soluti...

2025-05-29 19:17 2011

AI Meets Audit Powerhouse: Qualifyze Launches Quality Insights Platform to Help Global Pharma Manage Supplier Site Risk

FRANKFURT, Germany, May 29, 2025 /PRNewswire/ -- Qualifyze, already the global leader in third-party audit services for the pharmaceutical industry, announces the launch ofQuality Insights Platform, an AI-powered platform that transforms the world's largest pharmaceutical audit database into a st...

2025-05-29 18:23 2362

China's HER2-Targeted ADC Trastuzumab Rezetecan Gains NMPA Approval for HER2-Mutant NSCLC

SHANGHAI, May 29, 2025 /PRNewswire/ -- The National Medical Products Administration has recently granted approval for Trastuzumab rezetecan,China's first domestically developed antibody-drug conjugate (ADC), for treatment of adult patients with unresectable locally advanced or metastatic non-smal...

2025-05-29 17:27 1971

The Brain Prize: HM The King of Denmark presents prestigious prize to US and German scientists for seminal discoveries in brain cancer

Two pioneering scientists received The Brain Prize 2025 for their discoveries that open an entirely new way of thinking about and understanding brain cancers, and the potential strategies to treat them. COPENHAGEN, Denmark, May 29, 2025 /PRNewswire/ -- HM King Frederik of Denmark presented neur...

2025-05-29 15:00 2027

CPHI & PMEC China Sees Surge in International Attendance as Global Pharma Trade Outlook Strengthens

Record international participation reflects renewed momentum in pharma manufacturing and global sourcing, as easing tariffs fuel growth SHANGHAI, May 29, 2025 /PRNewswire/ -- CPHI & PMEC China  (June 24-26th) returns to the Shanghai New International Expo Center am...

2025-05-29 12:43 2402

Kexing Biopharm's GB18 project received clearance of IND application from NMPA and FDA

SHENZHEN, China, May 28, 2025 /PRNewswire/ -- On May 26th, Kexing Biopharm (688136.SH) announced that the National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application for its independently developed innovative product, GB18. Moreover, GB18 has previo...

2025-05-29 11:47 1961

Innovent Announces a Phase 3 Study of Picankibart (Anti-IL-23p19 Antibody) Completes First Participant Dosing, Exploring Biologics Switching Treatment for Psoriasis Patients with Prior Inadequate Response to Anti-IL-17 Antibodies

SAN FRANCISCO and SUZHOU, China, May 29, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic...

2025-05-29 10:23 2832

IonOpticks Generation 4 Aurora Series® sets a new benchmark in chromatography

MELBOURNE, Australia, May 29, 2025 /PRNewswire/ -- IonOpticks , developer of the highest-performing chromatography columns for mass spectrometry research, today announces the launch of its 4th Generation of Aurora Series columns. Following extensive testing by leading pr...

2025-05-29 05:00 1853

Metabolon's Untargeted Metabolomics Services Used for Landmark Study Linking a Western Dietary Pattern During Pregnancy to Neurodevelopment Disorders

Metabolomic profiling uncovered how maternal diet and metabolism may contribute to the risk of ADHD and autism in children MORRISVILLE, N.C., May 28, 2025 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, di...

2025-05-28 21:00 1930

Lunit Launches Enhanced Lunit INSIGHT CXR4, Secures CE MDR Certification for Expanded AI Capabilities

Next-generation AI solution introduces new clinical features and broader disease detection for chest X-rays SEOUL, South Korea, May 28, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced the official launch and CE certifi...

2025-05-28 21:00 2602

Long-term Commitment to Treating Endometriosis and Improving Women's Quality of Life – Gedeon Richter at the World Congress on Endometriosis

SYDNEY, May 28, 2025 /PRNewswire/ --Gedeon Richter had a strong presence at the World Congress of Endometriosis held this year in Sydney, Australia between 21-24 May 2025. As a Platinum Sponsor Gedeon Richter could reaffirm its inn...

2025-05-28 20:21 1711

IonOpticks Generation 4 Aurora Series® sets a new benchmark in chromatography

MELBOURNE, Australia, May 28, 2025 /PRNewswire/ -- IonOpticks , developer of the highest-performing chromatography columns for mass spectrometry research, today announces the launch of its 4th Generation of Aurora Series columns. Following extensive testing by leading pr...

2025-05-28 20:00 1578

Formosa Pharmaceuticals and Adalvo Limited Announce Licensing Agreement for Clobetasol Propionate Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain

TAIPEI, May 28, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Adalvo Limited ("Adalvo") in the European and Brazilian markets for exclusive rights to the commercialization of clobeta...

2025-05-28 20:00 2864

NX China Acquires GDP Certification for Shanghai and Lianyungang Facilities

- Establishing High-quality Pharmaceutical Logistics Service Systems - TOKYO, May 28, 2025 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereafter "NX China"), a group company of NIPPON EXPRESS HOLDINGS, INC., has received Good Distribution Practice (GDP) certification for air and ocean frei...

2025-05-28 15:00 2496

EpiVax Appoints Dr. Vibha Jawa to Lead Scientific Strategy as CSO

PROVIDENCE, R.I., May 28, 2025 /PRNewswire/ -- EpiVax, Inc., a leader in preclinical immunogenicity assessment for biologic therapeutics and vaccines, is pleased to announce the appointment ofVibha Jawa, PhD, FAAPS as Chief Scientific Officer. Dr. Jawa succeeds EpiVax founder and Executive Chairw...

2025-05-28 14:13 2376

Experimental Drug Development Centre Granted U.S. FDA Fast Track Designation for Antibody-Drug Conjugate EBC-129 to Treat Pancreatic Ductal Adenocarcinoma

* EBC-129 is the first made-in-Singapore antibody-drug conjugate (ADC) to enter clinical development. It selectively targets a tumour-specific N-glycosylated epitope on both CEACAM5 and CEACAM6.  * The Fast Track Designation highlights the potential of EBC-129 to address critical unmet needs ...

2025-05-28 14:00 2045

2025 World Brain Day Dedicated to Brain Health for All Ages

LONDON, May 28, 2025 /PRNewswire/ -- The World Federation of Neurology (WFN) is pleased to announce Brain Health for All Ages as the theme for the 2025 World Brain Day (WBD 2025), taking place on Tuesday, July 22. This global campaign aims to raise awareness of the importance of supporting brain ...

2025-05-28 13:00 1324

Perennial Holdings Signs Agreement with Guangzhou Metro to Establish the First Wholly Foreign-Owned Tertiary General Hospital in Guangzhou and Southern China

SINGAPORE, May 28, 2025 /PRNewswire/ -- Perennial Holdings Private Limited (" Perennial Holdings") entered into an agreement with Guangzhou Metro Group Co. Ltd ("Guangzhou Metro"), where Perennial Holdings will lease approximately 105,000 square metres of space and invest approximatelyRMB1 billion...

2025-05-28 12:18 3269

CARsgen's Satri-cel Granted Priority Review by the NMPA

SHANGHAI, May 28, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the Center for Drug Evaluation (CDE) ofChina's National Medical Products Administration (NMPA) has granted Priority R...

2025-05-28 12:10 2072
1 ... 88899091929394 ... 646